Understanding the genetics of small eyes and their complications
Defining the genetic landscape of nanophthalmos and the role of MYRF
This study is looking at how a specific gene called MYRF might be linked to nanophthalmos, a condition where the eyes are smaller than normal, which can cause serious vision issues, and it aims to help us understand more about the genetic causes of eye problems like high hyperopia and retinal degeneration.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10997360 on NIH RePORTER |
What this research studies
This research investigates the genetic factors contributing to nanophthalmos, a condition characterized by abnormally small eyes that can lead to severe vision problems. The study focuses on a specific gene, MYRF, which is believed to play a crucial role in eye development and function. By using advanced techniques like single-cell RNA sequencing, researchers aim to uncover how disruptions in MYRF can lead to various eye disorders, including high hyperopia and retinal degeneration. The findings could help identify new genetic contributors to these conditions and improve understanding of their underlying mechanisms.
Who could benefit from this research
Good fit: Ideal candidates for this research include children under 11 years old who have been diagnosed with nanophthalmos or related eye conditions.
Not a fit: Patients with eye conditions unrelated to genetic factors or those over the age of 11 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better diagnostic tools and treatments for children affected by nanophthalmos and related eye disorders.
How similar studies have performed: Other research has shown promising results in understanding genetic factors in eye disorders, suggesting that this approach could yield valuable insights.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Prasov, Lev — University of Michigan at Ann Arbor
- Study coordinator: Prasov, Lev
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.